Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MVXONCO-1 by Release Therapeutics for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
MVXONCO-1 is under clinical development by Release Therapeutics and currently in Phase II for Recurrent Head And Neck Squamous Cell...
MVXONCO-1 by Release Therapeutics for Oral Cavity (Mouth) Cancer: Likelihood of Approval
MVXONCO-1 is under clinical development by Release Therapeutics and currently in Phase II for Oral Cavity (Mouth) Cancer. According to...
MVXONCO-1 by Release Therapeutics for Pharyngeal Neoplasm: Likelihood of Approval
MVXONCO-1 is under clinical development by Release Therapeutics and currently in Phase II for Pharyngeal Neoplasm. According to GlobalData, Phase...
MVXONCO-1 by Release Therapeutics for Laryngeal Cancer: Likelihood of Approval
MVXONCO-1 is under clinical development by Release Therapeutics and currently in Phase II for Laryngeal Cancer. According to GlobalData, Phase...
MVXONCO-1 by Release Therapeutics for Chordoma: Likelihood of Approval
MVXONCO-1 is under clinical development by Release Therapeutics and currently in Phase I for Chordoma. According to GlobalData, Phase I...